ERBB2 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC), a group of breast cancers with the absence of oestrogen receptor and progesterone receptor and no overexpression of human epidermal growth factor receptor 2 (HER2), represents 10%–20% of invasive breast cancer.